America Is About to Go Over a Peptide Cliff The recent vote by the Pharmacy Compounding Advisory Committee has sent shockwaves through the medical community.
The committee recommended that compounding pharmacies be allowed to make and sell BPC 157, a peptide with a devoted following among some advocates for alternative medicine.
At its core, the debate over BPC 157 centers on safety and efficacy.